Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Ready for a Rebound: 7 Blue-Chips Set to Regain Their Market Mojo

Although blue-chip stocks to buy have a reputation for being slow and lumbering, these discounted ideas could swing higher.

Back to Basics: 3 Undervalued Non-Tech Stocks to Buy Now

Although technology enterprises seemingly get all the love, astute investors should consider undervalued non-tech stocks for upside.

7 Overvalued Stocks to Avoid Amid a Tricky Boom-Bust Cycle

While the market may be on a hot streak, some companies have gotten too hot, particularly these overvalued stocks to avoid.

7 Restaurant Stocks Sizzling With Potential in June 2023

Although some economic struggles may be evident, a last hurrah for the consumer may lift these top restaurant stocks to buy.

3 Signs the U.S. Housing Market Is Ready to Crash

Although the economy appears to be chugging along just fine, there may be signs of a possible U.S. housing market crash.

3 Stocks that Make Sense in a Confusing Market

Despite the positive headlines, something in the market feels wrong. Here are the top stable stock picks to lead you through the ambiguity.

How to Retire Rich: Biotech Stocks Edition

Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.

What’s Going on With Lordstown Motors (RIDE) Stock Today?

Although Lordstown Motors currently benefits from a sentiment surge in the market, RIDE stock remains a speculative venture.

IRBT Stock Alert: The $1.7 Billion Reason iRobot Is Up Today

With U.K. regulators giving a surprise approval for Amazon’s takeover bid of iRobot, IRBT stock soared on the critical lifeline.

3 Short-Squeeze Stocks Set for a Spectacular Gamma Squeeze Rally

If you can’t stand a dull day at the trading desk, these short-squeeze stocks to buy could spike your blood pressure and maybe your portfolio.